Turning Hormones Into Hope for Uterine Cancer - Kaitriana Colling

Uterine cancer deaths continue to rise despite advances in other cancers. Many patients who cannot undergo surgery rely on progestin therapy, which often fails. This research tests dozens of progestins on patient tumor and immune cells, identifying five more effective candidates. The goal is safer, personalised, fertility-preserving treatment for women with uterine cancer.